• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

NCCS Starburst 250px

What Caught Our Eye: House Passes ACA Repeal, Faces Senate Hurdles; Risky Prostate Cancer Treatment; Medical Debt; ‘Right to Try’; Rx Pricing

May 5, 2017/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Clinical Trials, Financial Toxicity, Health Equity, Pre-Existing Conditions NCCS News /by actualize
What Caught Our Eye (WCOE), May 5, 2017
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

Affordable Care Act

“Here’s What’s in the House-Approved Health Care Bill”

AHCA would:
– make changes to Medicaid
– ax tax penalty for failing to have coverage
Other proposals in the bill: https://t.co/JhithUyhuo

— NPR (@NPR) May 4, 2017

Via NPR — “House Republicans approved their plan to replace the Affordable Care Act on Thursday. Here’s a rundown of key provisions in the American Health Care Act and what would happen if the Senate approves them and the bill becomes law.”

Read More »


“Think You’re Not Affected by the GOP Health Bill? Think Again”

Think you’re not affected by the GOP health bill? Think again https://t.co/tOIy0IvkFA pic.twitter.com/qOIm45sgPu

— STAT (@statnews) May 5, 2017

Via STAT News — “With House Republicans on the verge of passing a long-awaited health care overhaul, the future of US insurance coverage hinges on three words: essential health benefits.”

Read More »


“5 Trump Health Care Promises that won’t Become Reality”

5 Trump health care promises that won't become reality https://t.co/6zeRY3RfwE via @ddiamond pic.twitter.com/9MZjGSblwH

— POLITICO (@politico) May 1, 2017

Via Politico — “Donald Trump broke the first campaign promise he made about Obamacare when he couldn’t scrap the law on the day he took office.”

Read More »


“Senate GOP Vows Big Changes for ObamaCare Bill”

Senate Republicans vow big changes for ObamaCare bill https://t.co/Wyl20OJHTD pic.twitter.com/nwl9FBstl3

— The Hill (@thehill) May 5, 2017

Via The Hill — “Senate Republicans plan to dramatically overhaul the House ObamaCare replacement bill that passed Thursday and are warning the process could take weeks.

“The House bill, the American Health Care Act, has raised an array of concerns among Senate Republicans, chiefly among lawmakers from swing states who are opposed to the cap on ObamaCare’s Medicaid expansion that would take effect in 2020.”

Read More »


Coping with Cancer

“Thousands of Men with Prostate Cancer Get Risky Treatment They Don’t Need. New Approaches Could Curb That”

New methods might spare thousands of men unneeded treatment for prostate cancer https://t.co/Dvj1KetSBk pic.twitter.com/m34RNuI9IX

— STAT (@statnews) May 5, 2017

Via STAT News — “They look like glowing jade necklaces of such unearthly brilliance they could be a Ming emperor’s. But if Dr. Gerardo Fernandez is right, the green fluorescent images of prostate cells could be even more valuable, at least to the thousands of men every year who unnecessarily undergo aggressive treatment for prostate cancer.”

Read More »


Cancer Policy

“Medical Debt Demystified (What You Owe Isn’t Necessarily What You Owe)”

Medical Debt Demystified (What You Owe Isn't Necessarily What You Owe). New post @forbeshealth @DukeU @dukemargolis https://t.co/bcEGFOOSA4 pic.twitter.com/JIxCgsFeqn

— Peter Ubel (@peterubel) May 5, 2017

Via Forbes.com — “When Lorie Duff was pregnant with her third child, she did what all good moms are supposed to do. She went to the ObGyn clinic for prenatal care. But she fell behind on the clinic payments. She only made about $25,000 a year managing an auto parts store while her husband stayed home with their kids. The out-of-pocket expenses were outpacing her ability to pay.”

Read More »


“‘Right to Try’ Won’t Give Patients Access To Experimental Drugs. Here’s What Will.”

Right to Try won’t give patients access to experimental drugs. What will? @arthurcaplan @ABatemanHouse @kellyfolkers https://t.co/4Moe1m51vj

— Health Affairs (@Health_Affairs) May 3, 2017

Via Health Affairs Blog — “Two federal bills, S.204: Trickett Wendler Right to Try Act of 2017, and a companion act in the House (H.R.878), claim to give terminally ill patients the ‘right to try’ experimental drugs outside of a clinical trial. They don’t.”

Read More »


“Poll: Majorities of Democrats, Republicans and Independents Support Actions to Lower Drug Costs, Including Allowing Americans to Buy Drugs from Canada”

NEW: Lowering cost of #prescription drugs a top health care priority across parties https://t.co/2nypM3Iqhw pic.twitter.com/mnkPG0a1aF

— KFF (Kaiser Family Foundation) (@KFF) May 1, 2017

Via Kaiser Family Foundation — “When asked about a series of health care priorities facing President Trump and Congress, six in 10 Americans (60%) identify lowering the cost of prescription drugs as a ‘top priority’ for President Trump and Congress – including majorities of Democrats, independents, and Republicans.”

Read More »


More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy


Tags: affordable care act, AHCA, cancer care, Cancer Survivorship, clinical trials, drug approvals, financial issues, pre-existing conditions, prostate cancer, repeal and replace, right to try, What Caught Our Eye
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png 250 250 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2017-05-05 16:39:072017-05-05 16:39:07What Caught Our Eye: House Passes ACA Repeal, Faces Senate Hurdles; Risky Prostate Cancer Treatment; Medical Debt; ‘Right to Try’; Rx Pricing
You might also like
20years Manufacturing problems responsible for shortages of cancer drugs, says Government Accountability Office
NCCS Starburst Thumbnail Journey Forward recognized for extraordinary contribution with Health Impact Award
Fotolia 23428619 S e1461260836640 NCCS Joins Cancer Groups to Oppose Graham-Cassidy ACA Repeal in a Letter to Senate Leadership
NCCS Starburst 250px Health Care Roundup: ACA Lawsuit Update; Chronic Pain Study; “Have Cancer, Must Travel;” “Survivorship Issues Reshape a Researcher’s Career;” More
NCCS Starburst 250px Health Care Roundup: More Drug Pricing News; Clinical Trial Challenges; Trump Promises Action on Surprise Billing; Fake Cancer Cures; More
Centers for Medicare and Medicaid NCCS Recommends Making COVID-19 Medicare Telehealth Coverage Expansion Permanent
NCCS Starburst 250px What Caught Our Eye: Multiple Proposals Continue to Weaken ACA Patient Protections; Breast Cancer Cost Survey; Editing Genes to Treat Cancer
20years Guest Video: Dr. Peter Ubel Talks About Values and Preference in Discussions of Costs of Care

Latest News

Coronavirus feat

COVID-19 Vaccines and Cancer: A Conversation with Cancer Expert Otis Brawley, MD

March 1, 2021
The National Coalition for Cancer Survivorship (NCCS) hosted a conversation on February…
Read more
https://canceradvocacy.org/wp-content/uploads/2020/03/Coronavirus-feat.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-03-01 11:49:192021-03-02 16:15:47COVID-19 Vaccines and Cancer: A Conversation with Cancer Expert Otis Brawley, MD
Canceradvocacy org default image

National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster

February 24, 2021
NOTE: This press release was originally published on the National Quality Forum (NQF)…
Read more
https://canceradvocacy.org/wp-content/uploads/2019/10/Canceradvocacy-org-default-image.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-24 21:01:392021-02-24 21:01:39National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster
HHS Humphrey bldg 1200

NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

February 19, 2021
The National Coalition for Cancer Survivorship (NCCS) joined with the Cancer Leadership…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-19 15:06:392021-02-24 19:29:10NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

NCCS Joins Cancer Organizations to Express Opposition to the American Health... Fotolia 23428619 S e1461260836640 ProtectOurCare 1024px ACA Update | May 5, 2017: AHCA Passes in House, Now Faces Major Obstacles in...
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute